PulseAugur
EN
LIVE 15:00:16
ENTITY Gilead Sciences

Gilead Sciences

PulseAugur coverage of Gilead Sciences — every cluster mentioning Gilead Sciences across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
5
5 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
RELATIONSHIPS
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 5 TOTAL
  1. TOOL · CL_285087 ·

    Cognizant and Gilead Sciences extend AI-driven DevOps partnership

    Cognizant has extended its partnership with Gilead Sciences for an additional five years. This collaboration aims to enhance AI-driven DevOps practices within Gilead Sciences. The extended agreement focuses on scaling t…

  2. COMMENTARY · CL_192113 ·

    CFOs taking on expanded operational roles, including COO duties

    Boards are increasingly expanding the responsibilities of Chief Financial Officers (CFOs) to include operational duties, with some companies merging the CFO and Chief Operating Officer (COO) roles. This trend is driven …

  3. RESEARCH · CL_97089 ·

    Healthcare M&A Surges to $65B Amid Patent Cliffs and Global Innovation

    The pharmaceutical industry is experiencing a significant surge in mergers and acquisitions, with $65 billion in deals during the first quarter of 2026. This trend is driven by looming patent expirations for major drugs…

  4. RESEARCH · CL_54026 ·

    Beyond LLMs: Why Scalable Enterprise AI Adoption Depends on Agent Logic

    Enterprises are increasingly adopting AI agents for core workflows, but face challenges in ensuring scalability, cost control, and governance. Key issues include the

  5. RESEARCH · CL_41121 ·

    Genesis AI partners with Incyte in $120M drug discovery deal

    Genesis Molecular AI has secured a significant partnership with Incyte, a global biotech company, valued at $120 million. This deal includes $80 million in upfront cash and a $40 million equity investment, with potentia…